Suppression of p53 and p21CIP1/WAF1 reduces arsenite-induced aneuploidy

Chemical Research in Toxicology

Volumn 23, Issue 2, 2010, Pages 357-364

  Salazar, Ana María ^a   Miller, Heather L ^b,e   McNeely, Samuel C ^b,d   Sordo, Monserrat ^a   Ostrosky Wegman, Patricia ^a   States, J Christopher ^b,c  

^a UNIVERSIDAD NACIONAL AUTÓNOMA DE MÉXICO   (Mexico)

^b University of Louisville School of Medicine   (United States)

^c University of LouisVille   (France)

^d MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^e KMPG LLP   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARSENITE SODIUM; CYCLIN DEPENDENT KINASE INHIBITOR 1; DNA; PROTEIN P53; SMALL INTERFERING RNA; TELOMERASE; ARSENIC TRIOXIDE; ARSENOUS ACID DERIVATIVE; CDKN1A PROTEIN, HUMAN; CYCLIN DEPENDENT KINASE INHIBITOR 1A; DEMECOLCINE; MITOMYCIN; TERATOGENIC AGENT;

ANEUPLOIDY; APOPTOSIS; ARTICLE; CENTROMERE; CHROMOSOME SEGREGATION; CONTROLLED STUDY; CYTOKINESIS; EXPOSURE; FIBROBLAST; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IMMOBILIZED CELL; MICRONUCLEUS; MITOSIS INHIBITION; CELL CULTURE; CELL PROLIFERATION; FLUORESCENCE IN SITU HYBRIDIZATION; GENE SILENCING; GENETICS; METABOLISM; WESTERN BLOTTING;

ANEUPLOIDY; ARSENITES; BLOTTING, WESTERN; CELL PROLIFERATION; CELLS, CULTURED; CYCLIN-DEPENDENT KINASE INHIBITOR P21; DEMECOLCINE; FIBROBLASTS; GENE KNOCKDOWN TECHNIQUES; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; MITOMYCIN; TERATOGENS; TUMOR SUPPRESSOR PROTEIN P53;

EID: 77049092090     PISSN: 0893228X     EISSN: 15205010     Source Type: Journal    
DOI: 10.1021/tx900353v     Document Type: Article

References (37)

1. Pihan, G. A., and Doxsey, S. J. (1999) The mitotic machinery as a source of genetic instability in cancer. Semin. Cancer Biol. 9, 289-302.
2. Aardema, M. J., Albertini, S., Arni, P., Henderson, L. M., Kirsch- Volders, M., Mackay, J. M., Sarrif, A. M., Stringer, D. A., and Taalman, R. D. (1998) Aneuploidy: a report of an ECETOC task force. Mutat. Res. 410, 3-79.
3. Vega, L., Gonsebatt, M. E., and Ostrosky-Wegman, P. (1995) Aneugenic effect of sodium arsenite on human lymphocytes in vitro: an individual susceptibility effect detected. Mutat. Res. 334, 365-373.
4. Yih, L. H., Ho, I. C., and Lee, T. C. (1997) Sodium arsenite disturbs mitosis and induces chromosome loss in human fibroblasts. Cancer Res. 57, 5051-5059.
5. Chakraborty, T., and De, M. (2009) Clastogenic effects of inorganic arsenic salts on human chromosomes in vitro. Drug Chem. Toxicol. 32, 169-173.
6. National Research Council (2001) Arsenic in Drinking Water: 2001 Update, National Academy Press, Washington DC.
7. Fukasawa, K. (2005) Centrosome amplification, chromosome instability and cancer development. Cancer Lett. 230, 6-19.
8. Lew, D. J., and Burke, D. J. (2003) The spindle assembly and spindle position checkpoints. Annu. Rev. Genet. 37, 251-282.
9. Tan, A. L., Rida, P. C., and Surana, U. (2005) Essential tension and constructive destruction: the spindle checkpoint and its regulatory links with mitotic exit. Biochem. J. 386, 1-13.
10. Shen, K. C., Heng, H., Wang, Y., Lu, S., Liu, G., Deng, C. X., Brooks, S. C., and Wang, Y. A. (2005) ATM and p21 cooperate to suppress aneuploidy and subsequent tumor development. Cancer Res. 65, 8747-8753.
11. Duensing, A., and Duensing, S. (2005) Guilt by association? p53 and the development of aneuploidy in cancer. Biochem. Biophys. Res. Commun. 331, 694-700.
12. Taylor, B. F., McNeely, S. C., Miller, H. L., Lehmann, G. M., McCabe, M. J., Jr., and States, J. C. (2006) p53 suppression of arsenite-induced mitotic catastrophe is mediated by p21CIP1/WAF1. J. Pharmacol. Exp. Ther. 318, 142-151.
13. Lanni, J. S., and Jacks, T. (1998) Characterization of the p53-dependent postmitotic checkpoint following spindle disruption. Mol. Cell. Biol. 18, 1055-1064.
14. Barboule, N., Chadebech, P., Baldin, V., Vidal, S., and Valette, A. (1997) Involvement of p21 in mitotic exit after paclitaxel treatment in MCF-7 breast adenocarcinoma cell line. Oncogene 15, 2867-2875.
15. McNeely, S. C., Taylor, B. F., and States, J. C. (2008) Mitotic arrestassociated apoptosis induced by sodium arsenite in A375 melanoma cells is BUBR1-dependent. Toxicol. Appl. Pharmacol. 231, 61-67.
16. McNeely, S. C., Belshoff, A. C., Taylor, B. F., Fan, T. W., McCabe, M. J., Jr., Pinhas, A. R., and States, J. C. (2008) Sensitivity to sodium arsenite in human melanoma cells depends upon susceptibility to arsenite-induced mitotic arrest. Toxicol. Appl. Pharmacol. 229, 252-261.
17. Wu, Y. C., Yen, W. Y., and Yih, L. H. (2008) Requirement of a functional spindle checkpoint for arsenite-induced apoptosis. J. Cell Biochem. 105, 678-687.
18. Coronado-Gonzalez, J. A., Del Razo, L. M., Garcia-Vargas, G., Sanmiguel-Salazar, F., and Escobedo-de la Pena, J. (2007) Inorganic arsenic exposure and type 2 diabetes mellitus in Mexico. Environ. Res 104, 383-389.
19. States, J. C., Srivastava, S., Chen, Y., and Barchowsky, A. (2009) Arsenic and cardiovascular disease. Toxicol. Sci. 107, 312-323.
20. Chou, W. C., and Dang, C. V. (2005) Acute promyelocytic leukemia: recent advances in therapy and molecular basis of response to arsenic therapies. Curr. Opin. Hematol. 12, 1-6.
21. Taylor, B. F., McNeely, S. C., Miller, H. L., and States, J. C. (2008) Arsenite-induced mitotic death involves stress response and is independent of tubulin polymerization. Toxicol. Appl. Pharmacol. 230, 235-246.
22. Shen, Z. Y., Shen, J., Cai, W. J., Hong, C., and Zheng, M. H. (2000) The alteration of mitochondria is an early event of arsenic trioxide induced apoptosis in esophageal carcinoma cells. Int. J. Mol. Med. 5, 155-158.
23. Cai, X., Shen, Y. L., Zhu, Q., Jia, P. M., Yu, Y., Zhou, L., Huang, Y., Zhang, J. W., Xiong, S. M., Chen, S. J., Wang, Z. Y., Chen, Z., and Chen, G. Q. (2000) Arsenic trioxide-induced apoptosis and differentiation are associated respectively with mitochondrial transmembrane potential collapse and retinoic acid signaling pathways in acute promyelocytic leukemia. Leukemia 14, 262-270.
24. Uslu, R., Sanli, U. A., Sezgin, C., Karabulut, B., Terzioglu, E., Omay, S. B., and Goker, E. (2000) Arsenic trioxide-mediated cytotoxicity and apoptosis in prostate and ovarian carcinoma cell lines. Clin. Cancer Res. 6, 4957-4964.
25. 3) in the orthotopic metastasis model of androgen-independent prostate cancer. Cancer Res. 61, 5432-5440.
26. 3) reduces the invasive and metastatic properties of cervical cancer cells in vitro and in vivo. Gynecol. Oncol. 106, 400-406.
27. Huang, S., Huang, C. F., and Lee, T. (2000) Induction of mitosismediated apoptosis by sodium arsenite in HeLa S3 cells. Biochem. Pharmacol. 60, 771-780.
28. States, J. C., Reiners, J. J., Jr., Pounds, J. G., Kaplan, D. J., Beauerle, B. D., McNeely, S. C., Mathieu, P., and McCabe, M. J., Jr. (2002) Arsenite disrupts mitosis and induces apoptosis in SV40-transformed human skin fibroblasts. Toxicol. Appl. Pharmacol. 180, 83-91.
29. Cai, X., Yu, Y., Huang, Y., Zhang, L., Jia, P. M., Zhao, Q., Chen, Z., Tong, J. H., Dai, W., and Chen, G. Q. (2003) Arsenic trioxide-induced mitotic arrest and apoptosis in acute promyelocytic leukemia cells. Leukemia 17, 1333-1337.
30. McCabe, M. J., Jr., Singh, K. P., Reddy, S. A., Chelladurai, B., Pounds, J. G., Reiners, J. J., Jr., and States, J. C. (2000) Sensitivity of myelomonocytic leukemia cells to arsenite-induced cell cycle disruption, apoptosis, and enhanced differentiation is dependent on the interrelationship between arsenic concentration, duration of treatment, and cell cycle phase. J. Pharmacol. Exp. Ther. 295, 724-733.
31. Yih, L. H., Hsueh, S. W., Luu, W. S., Chiu, T. H., and Lee, T. C. (2005) Arsenite induces prominent mitotic arrest via inhibition of G2 checkpoint activation in CGL-2 cells. Carcinogenesis 26, 53-63.
32. McNeely, S. C., Xu, X., Taylor, B. F., Zacharias, W., McCabe, M. J., Jr., and States, J. C. (2006) Exit from arsenite-induced mitotic arrest is p53 dependent. Environ. Health Perspect. 114, 1401-1406.
33. Porter, P. C., Clark, D. R., McDaniel, L. D., McGregor, W. G., and States, J. C. (2006) Telomerase-immortalized human fibroblasts retain UV-induced mutagenesis and p53-mediated DNA damage responses. DNA Repair (Amsterdam) 5, 61-70.
34. Salazar, A. M., Sordo, M., and Ostrosky-Wegman, P. (2009) Relationship between micronuclei formation and p53 induction. Mutat. Res. 672, 124-128.
35. Fukasawa, K., Choi, T., Kuriyama, R., Rulong, S., and Vande Woude, G. F. (1996) Abnormal centrosome amplification in the absence of p53. Science 271, 1744-1747.
36. Yih, L. H., Tseng, Y. Y., Wu, Y. C., and Lee, T. C. (2006) Induction of centrosome amplification during arsenite-induced mitotic arrest in CGL-2 cells. Cancer Res. 66, 2098-2106.
37. Yu, X., Robinson, J. F., Gribble, E., Hong, S. W., Sidhu, J. S., and Faustman, E. M. (2008) Gene expression profiling analysis reveals arsenic-induced cell cycle arrest and apoptosis in p53-proficient and p53-deficient cells through differential gene pathways. Toxicol. Appl. Pharmacol. 233, 389-403.